MCMASTER UNIVERSITY – Trademark Portfolio
Entity Type: 03
MCMASTER UNIVERSITY holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MMM and MMM MCMASTER MOLECULAR MEDIUM. The owner is based in HAMILTON, ONTARIO.
1280 MAIN STREET WEST
HAMILTON, ONTARIO L8S 4L8 , CA
Showing of trademarks Trademarks
Trademark Classifications
MCMASTER UNIVERSITY's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does MCMASTER UNIVERSITY have?
MCMASTER UNIVERSITY has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 cancelled.
What trademark classes does MCMASTER UNIVERSITY file in?
MCMASTER UNIVERSITY files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are MCMASTER UNIVERSITY's most well-known trademarks?
MCMASTER UNIVERSITY's registered trademark portfolio includes well-known marks such as MMM and MMM MCMASTER MOLECULAR MEDIUM. These are among 2 currently registered trademarks in the portfolio.
What is MCMASTER UNIVERSITY's trademark registration success rate?
MCMASTER UNIVERSITY has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.